Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology, Oncology, Other Applications), by Product Type (Conventional catheters, Scoring balloon catheters, Drug eluting balloon (DEB) catheters, Cutting balloon catheters, Others) and by End User (Hospitals, Ambulatory surgical centers, Specialty clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A10267

Pages: NA

Charts: NA

Tables: NA

In angiography, catheters are used for diagnosis of the disorders. These catheters are a very tube made up of plastic for inserting into the artery from a small opening in the skin. Once the catheter reaches the examination area, the contrast material is inoculated by the tube, and pictures are collected by a small dose of x-rays or radiations.

    

Angiographic catheter utilizes injections and imaging of the x-rays guidance and an injection of contrast material for the examination of the blood vessels of the body parts which helps in analyzing the abnormalities of the body like atherosclerosis and disorders like aneurysms. The benefit of catheters is that they can help in the diagnosis and the treatment of the disease at a single time. The images produced by the technique are very clear, detailed, and accurate. These images are for the blood vessels and help in minimizing any chances of surgery.

Angiography makes use of computed tomography (CT) catheters along with magnetic resonance imaging (MRI) as well.

COVID-19 scenario analysis:

To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

Owing to such factors, COVID 19 is expected to have a significant impact on the Angiographic Catheters market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Significant rise in Cath labs, growing fondness of minimally invasive surgeries, rising cases of cardiovascular diseases are the major factors propelling the growth of the angiographic catheters.

Moreover, increasing geriatric population; lifestyle of people changing to sedentary, hypertension, and obesity levels increasing are also some of the causes for the angiographic catheters market.

Along with this, surgeries for heart diseases and upgrades in the technologies in the medical devices, the interest of the government in the expenditure for healthcare infrastructure development are affecting the growth of the angiographic catheters market.

Rise in the domestic income is allowing the population to spend more on healthcare and the policies for the reimbursement are also helping the customers in accepting the treatments.

The major manufacturing companies are working on upgrading their technologies by investing in the research and development activities are also propelling and creating opportunities for the angiographic catheters market.

On the other hand, surgeries are very expensive and the strict regulation policies by the government for the approval of the products are the major challenges faced by the angiographic catheters market.

The therapies are very unconventional and there is a very low availability are also hampering the angiographic catheters market.

New product launches and acquisitions to flourish the market:

On August 6th, 2018, Pulse Medical Imaging Technology Co. introduced a medical equipment named, AngioPlus system, and has been approved by the health authorities of China.

Surge in usage in hospitals applications:

Hospitals, specialty clinics, ambulatory surgical centers, and other healthcare facilities are the major consumers of the angiographic catheters. Amongst them, hospitals are the biggest end-users in the market. This growth is observed due to the digitization of the cath labs rise in the cases of cardiac diseases.

Key benefits of the report:

  • This study presents the analytical depiction of the global Angiographic Catheters industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global market share.
  • The current market is quantitatively analyzed to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Angiographic Catheters market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Angiographic Catheters Market research report:

  • What are the leading market players active in the Angiographic Catheters market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps? 

Key Market Segments

  • By Application
    • Coronary
    • Endovascular
    • Neurology
    • Oncology
    • Other Applications
  • By Product Type
    • Conventional catheters
    • Scoring balloon catheters
    • Drug eluting balloon (DEB) catheters
    • Cutting balloon catheters
    • Others
  • By End User
    • Hospitals
    • Ambulatory surgical centers
    • Specialty clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • OSCOR, Inc.
  • Cardinal Health
  • Terumo Europe NV
  • BVM Medical Limited
  • B. Braun Melsungen AG
  • iVascular SLU
  • Boston Scientific Corporation
  • AngioDynamics, Inc
  • Medtronic
  • Spectranetics
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ANGIOGRAPHIC CATHETERS MARKET, BY APPLICATION

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Application

    • 4.2. Coronary

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Endovascular

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Neurology

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Oncology

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Other Applications

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: ANGIOGRAPHIC CATHETERS MARKET, BY PRODUCT TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Product Type

    • 5.2. Conventional Catheters

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Scoring Balloon Catheters

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Drug Eluting Balloon (DEB) Catheters

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Cutting Balloon Catheters

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: ANGIOGRAPHIC CATHETERS MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Specialty Clinics

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: ANGIOGRAPHIC CATHETERS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Application

      • 7.2.3. Market Size and Forecast, By Product Type

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Angiographic Catheters Market

        • 7.2.6.1. Market Size and Forecast, By Application
        • 7.2.6.2. Market Size and Forecast, By Product Type
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Angiographic Catheters Market

        • 7.2.7.1. Market Size and Forecast, By Application
        • 7.2.7.2. Market Size and Forecast, By Product Type
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Angiographic Catheters Market

        • 7.2.8.1. Market Size and Forecast, By Application
        • 7.2.8.2. Market Size and Forecast, By Product Type
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Application

      • 7.3.3. Market Size and Forecast, By Product Type

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Angiographic Catheters Market

        • 7.3.6.1. Market Size and Forecast, By Application
        • 7.3.6.2. Market Size and Forecast, By Product Type
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Angiographic Catheters Market

        • 7.3.7.1. Market Size and Forecast, By Application
        • 7.3.7.2. Market Size and Forecast, By Product Type
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Angiographic Catheters Market

        • 7.3.8.1. Market Size and Forecast, By Application
        • 7.3.8.2. Market Size and Forecast, By Product Type
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Angiographic Catheters Market

        • 7.3.9.1. Market Size and Forecast, By Application
        • 7.3.9.2. Market Size and Forecast, By Product Type
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Angiographic Catheters Market

        • 7.3.10.1. Market Size and Forecast, By Application
        • 7.3.10.2. Market Size and Forecast, By Product Type
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Angiographic Catheters Market

        • 7.3.11.1. Market Size and Forecast, By Application
        • 7.3.11.2. Market Size and Forecast, By Product Type
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Angiographic Catheters Market

        • 7.3.12.1. Market Size and Forecast, By Application
        • 7.3.12.2. Market Size and Forecast, By Product Type
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Application

      • 7.4.3. Market Size and Forecast, By Product Type

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Angiographic Catheters Market

        • 7.4.6.1. Market Size and Forecast, By Application
        • 7.4.6.2. Market Size and Forecast, By Product Type
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Angiographic Catheters Market

        • 7.4.7.1. Market Size and Forecast, By Application
        • 7.4.7.2. Market Size and Forecast, By Product Type
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Angiographic Catheters Market

        • 7.4.8.1. Market Size and Forecast, By Application
        • 7.4.8.2. Market Size and Forecast, By Product Type
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Angiographic Catheters Market

        • 7.4.9.1. Market Size and Forecast, By Application
        • 7.4.9.2. Market Size and Forecast, By Product Type
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Angiographic Catheters Market

        • 7.4.10.1. Market Size and Forecast, By Application
        • 7.4.10.2. Market Size and Forecast, By Product Type
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Angiographic Catheters Market

        • 7.4.11.1. Market Size and Forecast, By Application
        • 7.4.11.2. Market Size and Forecast, By Product Type
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Angiographic Catheters Market

        • 7.4.12.1. Market Size and Forecast, By Application
        • 7.4.12.2. Market Size and Forecast, By Product Type
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Angiographic Catheters Market

        • 7.4.13.1. Market Size and Forecast, By Application
        • 7.4.13.2. Market Size and Forecast, By Product Type
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Angiographic Catheters Market

        • 7.4.14.1. Market Size and Forecast, By Application
        • 7.4.14.2. Market Size and Forecast, By Product Type
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Application

      • 7.5.3. Market Size and Forecast, By Product Type

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Angiographic Catheters Market

        • 7.5.6.1. Market Size and Forecast, By Application
        • 7.5.6.2. Market Size and Forecast, By Product Type
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Angiographic Catheters Market

        • 7.5.7.1. Market Size and Forecast, By Application
        • 7.5.7.2. Market Size and Forecast, By Product Type
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Angiographic Catheters Market

        • 7.5.8.1. Market Size and Forecast, By Application
        • 7.5.8.2. Market Size and Forecast, By Product Type
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Angiographic Catheters Market

        • 7.5.9.1. Market Size and Forecast, By Application
        • 7.5.9.2. Market Size and Forecast, By Product Type
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Angiographic Catheters Market

        • 7.5.10.1. Market Size and Forecast, By Application
        • 7.5.10.2. Market Size and Forecast, By Product Type
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Angiographic Catheters Market

        • 7.5.11.1. Market Size and Forecast, By Application
        • 7.5.11.2. Market Size and Forecast, By Product Type
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. OSCOR, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Medtronic

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Cardinal Health

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Terumo Europe NV

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. AngioDynamics, Inc

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. BVM Medical Limited

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. B. Braun Melsungen AG

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Spectranetics

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. IVascular SLU

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Boston Scientific Corporation

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ANGIOGRAPHIC CATHETERS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR CORONARY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR ENDOVASCULAR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR NEUROLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR ONCOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ANGIOGRAPHIC CATHETERS MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR CONVENTIONAL CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR SCORING BALLOON CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR DRUG ELUTING BALLOON (DEB) CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR CUTTING BALLOON CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL ANGIOGRAPHIC CATHETERS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR SPECIALTY CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL ANGIOGRAPHIC CATHETERS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL ANGIOGRAPHIC CATHETERS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA ANGIOGRAPHIC CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. U.S. ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. U.S. ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 25. U.S. ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. CANADA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. CANADA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. CANADA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 31. MEXICO ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE ANGIOGRAPHIC CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. FRANCE ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. FRANCE ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. GERMANY ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. GERMANY ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. ITALY ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. ITALY ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 44. ITALY ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. SPAIN ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. SPAIN ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. UK ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. UK ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 50. UK ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. RUSSIA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. RUSSIA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. REST OF EUROPE ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 56. REST OF EUROPE ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC ANGIOGRAPHIC CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. ASIA-PACIFIC ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. ASIA-PACIFIC ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. CHINA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. CHINA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. CHINA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. JAPAN ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. JAPAN ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. INDIA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. INDIA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 69. INDIA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH KOREA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. SOUTH KOREA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. AUSTRALIA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 75. AUSTRALIA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. THAILAND ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 78. THAILAND ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. MALAYSIA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 81. MALAYSIA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. INDONESIA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 84. INDONESIA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 87. REST OF ASIA PACIFIC ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA ANGIOGRAPHIC CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. LAMEA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 91. LAMEA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 93. BRAZIL ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 94. BRAZIL ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 96. SOUTH AFRICA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 97. SOUTH AFRICA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. SAUDI ARABIA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 100. SAUDI ARABIA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. UAE ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 102. UAE ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 103. UAE ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 105. ARGENTINA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 106. ARGENTINA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA ANGIOGRAPHIC CATHETERS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 108. REST OF LAMEA ANGIOGRAPHIC CATHETERS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 109. REST OF LAMEA ANGIOGRAPHIC CATHETERS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 110. OSCOR, INC.: KEY EXECUTIVES
  • TABLE 111. OSCOR, INC.: COMPANY SNAPSHOT
  • TABLE 112. OSCOR, INC.: OPERATING SEGMENTS
  • TABLE 113. OSCOR, INC.: PRODUCT PORTFOLIO
  • TABLE 114. OSCOR, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. MEDTRONIC: KEY EXECUTIVES
  • TABLE 116. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 117. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 118. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 119. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. CARDINAL HEALTH: KEY EXECUTIVES
  • TABLE 121. CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 122. CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 123. CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 124. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. TERUMO EUROPE NV: KEY EXECUTIVES
  • TABLE 126. TERUMO EUROPE NV: COMPANY SNAPSHOT
  • TABLE 127. TERUMO EUROPE NV: OPERATING SEGMENTS
  • TABLE 128. TERUMO EUROPE NV: PRODUCT PORTFOLIO
  • TABLE 129. TERUMO EUROPE NV: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. ANGIODYNAMICS, INC: KEY EXECUTIVES
  • TABLE 131. ANGIODYNAMICS, INC: COMPANY SNAPSHOT
  • TABLE 132. ANGIODYNAMICS, INC: OPERATING SEGMENTS
  • TABLE 133. ANGIODYNAMICS, INC: PRODUCT PORTFOLIO
  • TABLE 134. ANGIODYNAMICS, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. BVM MEDICAL LIMITED: KEY EXECUTIVES
  • TABLE 136. BVM MEDICAL LIMITED: COMPANY SNAPSHOT
  • TABLE 137. BVM MEDICAL LIMITED: OPERATING SEGMENTS
  • TABLE 138. BVM MEDICAL LIMITED: PRODUCT PORTFOLIO
  • TABLE 139. BVM MEDICAL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 141. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 142. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 143. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 144. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. SPECTRANETICS: KEY EXECUTIVES
  • TABLE 146. SPECTRANETICS: COMPANY SNAPSHOT
  • TABLE 147. SPECTRANETICS: OPERATING SEGMENTS
  • TABLE 148. SPECTRANETICS: PRODUCT PORTFOLIO
  • TABLE 149. SPECTRANETICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. IVASCULAR SLU: KEY EXECUTIVES
  • TABLE 151. IVASCULAR SLU: COMPANY SNAPSHOT
  • TABLE 152. IVASCULAR SLU: OPERATING SEGMENTS
  • TABLE 153. IVASCULAR SLU: PRODUCT PORTFOLIO
  • TABLE 154. IVASCULAR SLU: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 155. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 156. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 157. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 158. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 159. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOGRAPHIC CATHETERS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ANGIOGRAPHIC CATHETERS MARKET
  • FIGURE 3. SEGMENTATION ANGIOGRAPHIC CATHETERS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ANGIOGRAPHIC CATHETERS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANGIOGRAPHIC CATHETERS MARKET
  • FIGURE 11. ANGIOGRAPHIC CATHETERS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 12. ANGIOGRAPHIC CATHETERS MARKET FOR CORONARY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ANGIOGRAPHIC CATHETERS MARKET FOR ENDOVASCULAR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ANGIOGRAPHIC CATHETERS MARKET FOR NEUROLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. ANGIOGRAPHIC CATHETERS MARKET FOR ONCOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. ANGIOGRAPHIC CATHETERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. ANGIOGRAPHIC CATHETERS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 18. ANGIOGRAPHIC CATHETERS MARKET FOR CONVENTIONAL CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. ANGIOGRAPHIC CATHETERS MARKET FOR SCORING BALLOON CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. ANGIOGRAPHIC CATHETERS MARKET FOR DRUG ELUTING BALLOON (DEB) CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. ANGIOGRAPHIC CATHETERS MARKET FOR CUTTING BALLOON CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. ANGIOGRAPHIC CATHETERS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. ANGIOGRAPHIC CATHETERS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 24. ANGIOGRAPHIC CATHETERS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. ANGIOGRAPHIC CATHETERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. ANGIOGRAPHIC CATHETERS MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. ANGIOGRAPHIC CATHETERS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: ANGIOGRAPHIC CATHETERS MARKET
  • FIGURE 34. TOP PLAYER POSITIONING, 2024
  • FIGURE 35. OSCOR, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. OSCOR, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. OSCOR, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. CARDINAL HEALTH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. TERUMO EUROPE NV: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. TERUMO EUROPE NV: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. TERUMO EUROPE NV: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. ANGIODYNAMICS, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. ANGIODYNAMICS, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. ANGIODYNAMICS, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. BVM MEDICAL LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. BVM MEDICAL LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. BVM MEDICAL LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. SPECTRANETICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. SPECTRANETICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. SPECTRANETICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. IVASCULAR SLU: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. IVASCULAR SLU: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. IVASCULAR SLU: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Angiographic Catheters Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue